sFlt-1 as a Potential Marker for Early Detection of Pre-Eclampsia

sFlt-1 as a Potential Marker for Early Detection of Pre-Eclampsia

This research focuses on a serious condition during pregnancy called pre-eclampsia, which affects about 5% of pregnant women. It usually shows up after the 20th week and is marked by high blood pressure and protein in the urine. If not managed, it can lead to dangerous complications for both the mother and the baby, including seizures, liver and kidney issues, and even death.

Prescription Patterns of Novel Heart Failure Medications: Analysis from a Safety Net Hospital System

Prescription Patterns of Novel Heart Failure Medications: Analysis from a Safety Net Hospital System

Recent prescription trends for novel heart failure medications were analyzed at a major Kansas City safety net hospital, focusing on the utilization patterns of sacubitril/valsartan and SGLT2 inhibitors in underserved populations. The study examined prescription data from October 2021 to October 2022, involving 769 patients receiving sacubitril/valsartan and 2,287 patients prescribed SGLT2 inhibitors.

Optimizing Heart Failure Outcomes: The Synergy of Lifestyle Modifications and Medications

Optimizing Heart Failure Outcomes: The Synergy of Lifestyle Modifications and Medications

Heart failure (HF) is a growing problem worldwide, causing high healthcare costs and lower quality of life. While medications are key, lifestyle changes like diet, exercise, and managing weight, smoking, and stress are also important. These changes, along with medicines, can improve how well patients do, reduce hospital visits, and help the medicines work better.

Utilizing Existing Cardiovascular Data for Better Hypertension Detection and Treatment

Utilizing Existing Cardiovascular Data for Better Hypertension Detection and Treatment

The article is a study of cardiovascular health, looking into how a given disease or therapy affects cardiovascular health. Researchers conducted a study to look at how various factors, including drugs, lifestyle, or medical therapies, affect heart disease, heart attack, or cardiovascular function as a whole. The study tracked a cohort of cardiovascular patients over a period of time to see how their condition progressed and if the treatments were working.

Oral Semaglutide Lowers Heart Attack and Stroke Risk in Diabetes

Oral Semaglutide Lowers Heart Attack and Stroke Risk in Diabetes

This case report describes a rare and extremely malignant tumor named Primary Cardiac Lymphoma (PCL), which occurs in the heart. Because of the rarity of cardiac cancer, its diagnosis generally presents major challenges. The report describes the case of a 67-year-old male patient who initially came in for medical assessment after experiencing recurrent attacks of syncope.

Beating the Odds: A Rare Case of Heart Lymphoma with Severe Complications

Beating the Odds: A Rare Case of Heart Lymphoma with Severe Complications

This case report describes a rare and extremely malignant tumor named Primary Cardiac Lymphoma (PCL), which occurs in the heart. Because of the rarity of cardiac cancer, its diagnosis generally presents major challenges. The report describes the case of a 67-year-old male patient who initially came in for medical assessment after experiencing recurrent attacks of syncope.